Company intelligence / Profile preview
Amnio Technology
Phoenix, Arizona, United Statesamniotechnology.com ↗
- Ownership
- Private
- Employees
- ~18
- Development stage
- Commercial
01
Overview
Amnio Technology manufactures and distributes amniotic tissue-derived products. The FDA has issued a warning letter on October 1, 2024, stating that some of their products should be regulated as drugs and biologics rather than HCT/Ps (human cell, tissue, or cellular or tissue-based products)[8][10].
- Therapeutic areas
- DermatologyRheumatology
- Modalities
- Amniotic tissue-derived allograftsAmniotic membrane productsAmniotic fluid products
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Pinnacle Transplant Technologies (contract manufacturer)[8]
Beyond the preview
Go deeper on Amnio Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Amnio Technology.